Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-07-12

Clinical Trial Update: Evaluation of the Efficiency of the Bone Substitute Cerament-G Locally Delivering Gentamicin in the Treatment of Chronic Osteomyelitis of Long Bones [NA]

View source ↗

Summary

A clinical trial evaluating Cerament-G, a gentamicin-eluting bone substitute, for the treatment of chronic osteomyelitis of long bones; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cerament-G (Gentamicin-eluting bone graft substitute)

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Osteomyelitis Chronic | NA | Status: RECRUITING